Manufacturer record
Medisky Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Medisky Pharmaceuticals Pvt. Ltd (Gujarat) were declared Not of Standard Quality between December 2022 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Medisky Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac and Paracetamol | T251109Mfg 2025-11 · Exp 2027-10 | MisbrandadMisbranded | SDTL,ChhattisgarhState lab | Jun 2026 |
| Aceclofenac & Paracetamol Tablets | T250216Mfg 2025-02 · Exp 2027-01 | The sample does not conform to Addendum 2024 of I.P 2022 with respect to the Assay of Aceclofenac.Assay | CDTL, IndoreCDSCO lab | Jan 2026 |
| Nifedipine Sustained Release Tablets IP 10 mg | T250809Mfg 2025-08 · Exp 2027-07 | Dissolution Stage 1Dissolution | Food & Drugs Laboratory, VadodaraState lab | Nov 2025 |
| Nifedipine Sustain Release Tablets I.P. 20 mg | T230307Mfg 2023-03 · Exp 2025-02 | DissolutionDissolution | CDL KolkataCDSCO lab | Aug 2023 |
| Fenosky - 200 (Fenofibrate Tablets I.P. 200 mg) | T220209Mfg 2022-02 · Exp 2024-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Dec 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.